Clinical applications of hallucinogens: a review

Cites (531)

Items 201–400 of 531

1. Antagonism of the effects of the hallucinogen dom and the purported 5-HT agonist quipazine by 5-HT2 antagonists
   Glennon, Richard A., Young, Richard, Rosecrans, John A. · 1983 · European Journal of Pharmacology
2. Effects of iboga alkaloids on morphine and cocaine self-administration in rats: relationship to tremorigenic effects and to effects on dopamine release in nucleus accumbens and striatum
   S.D. Glick, Martin E. Kuehne, John Raucci, Timothy E. Wilson, Denise M. Larson, Richard W. Keller, Jeffrey N. Carlson · 1994 · Brain Research
3. Some Neurophysiological Aspects of Serotonin
   D. W. Woolley, E Shaw · 1954 · BMJ
4. Psychological and Cognitive Effects of Long-Term Peyote Use Among Native Americans
   John H. Halpern, Andrea R. Sherwood, James I. Hudson, Deborah A Yurgelun-Todd, Harrison Graham Pope · 2005 · Biological Psychiatry
5. Psychedelic medicine: a re-emerging therapeutic paradigm
   Tupper, Kenneth W., Wood, Evan, Yensen, Richard, Johnson, Matthew W. · 2015 · Canadian Medical Association Journal
6. The ibogaine medical subculture
   Kenneth Alper, Howard S. Lotsof, Charles D. Kaplan · 2007 · Journal of Ethnopharmacology
7. Human psychobiology of MDMA or ‘Ecstasy’: an overview of 25 years of empirical research
   Andrew C. Parrott · 2013 · Human Psychopharmacology Clinical and Experimental
8. Mechanisms of change in mindfulness-based cognitive therapy for depression: preliminary evidence from a randomized controlled trial
   Shahar, Ben, Britton, Willoughby B., Sbarra, David A., Figueredo, Aurelio Jose, Bootzin, Richard R. · 2010 · International Journal of Cognitive Therapy
9. 100 years of ibogaine: neurochemical and pharmacological actions of a putative anti-addictive drug.
   Piotr Popik, Richard Thomas Layer, Phil Skolnick · 1995 · Pharmacological Reviews
10. Neurochemistry and Neurotoxicity of 3,4‐Methylenedioxymethamphetamine (MDMA, “Ecstasy”)
    Dennis J. McKenna, Stephen J. Peroutka · 1990 · Journal of Neurochemistry
11. Single Versus Repeated Sessions of Ketamine-Assisted Psychotherapy for People with Heroin Dependence
    Evgeny M. Krupitsky, Andrey M. Burakov, I. V. Dunaevsky, Tatyana N. Romanova, Tatyana Y. Slavina, A. Y. Grinenko · 2007 · Journal of Psychoactive Drugs
12. Mescaline-induced psychopathological, neuropsychological, and neurometabolic effects in normal subjects: Experimental psychosis as a tool for psychiatric research
    Leo Hermle, Matthias Fünfgeld, Godehard Oepen, Hanno Botsch, Dieter Borchardt, Euphrosyne Gouzoulis, Rose A. Fehrenbach, Manfred Spitzer · 1992 · Biological Psychiatry
13. A Method of Conducting Therapeutic Sessions with MDMA
    George R. Greer, Requa Tolbert · 1998 · Journal of Psychoactive Drugs
14. Inhibitory effects of ibogaine on cocaine self-administration in rats
    Susanne L.T. Cappendijk, Michailo R. Dzoljic · 1993 · European Journal of Pharmacology
15. Cannabinoid-Induced Immune Suppression and Modulation of Antigen-Presenting Cells
    Klein, Thomas W., Cabral, Guy A. · 2006 · Journal of Neuroimmune Pharmacology
16. Investigation of sex-dependent effects of cannabis in daily cannabis smokers
    Ziva D. Cooper, Margaret Haney · 2014 · Drug and Alcohol Dependence
17. Antidepressant-like effect of harmane and other β-carbolines in the mouse forced swim test
    Farzin, Davood, Mansouri, Nazanin · 2006 · European Neuropsychopharmacology
18. Chromosomal damage in human leukocytes induced by lysergic acid diethylamide
    Maimon M. Cohen, Michelle J. Marinello, Nathan Back · 1967 · PsycEXTRA Dataset
19. Neuroendocrinological mechanisms of actions of antidepressant drugs
    Schüle, C. · 2007 · Journal of Neuroendocrinology
20. Ketamine
    Gyula Bokor, Peter Anderson · 2014 · Journal of Pharmacy Practice
21. The use of cannabinoids as anticancer agents
    Guillermo Velasco, Sonia Hernández‐Tiedra, David Dávila, Mar Lorente · 2015 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
22. A chemotaxonomic analysis of terpenoid variation in Cannabis
    Karl W. Hillig · 2004 · Biochemical Systematics and Ecology
23. The prosocial effects of 3,4-methylenedioxymethamphetamine (MDMA): Controlled studies in humans and laboratory animals
    Kamilar-Britt, Philip, Bedi, Gillinder · 2015 · Neuroscience & Biobehavioral Reviews
24. Prehistoric peyote use: Alkaloid analysis and radiocarbon dating of archaeological specimens of Lophophora from Texas
    Hesham Rushdey El-Seedi, Peter A. G. M. De Smet, Olof Beck, Göran Possnert, Jan G. Bruhn · 2005 · Journal of Ethnopharmacology
25. PAHNKE'S "GOOD FRIDAY EXPERIMENT' A LONG-TERM FOLLOW-UP AND METHODOLOGICAL CRITIQUE
    Richard Doblin · 1991
26. CHARACTERIZATION OF THREE NEW PSYCHOTOMIMETICS
    T. Alexander, David E. Nichols · 1978 · Elsevier eBooks
27. Effects of Ketamine in Treatment-Refractory Obsessive-Compulsive Disorder
    Bloch, Michael H., Wasylink, Suzanne, Landeros-Weisenberger, Angeli, Panza, Kaitlyn E., Billingslea, Eileen, Leckman, James F., Krystal, John H., Bhagwagar, Zubin, Sanacora, Gerard, Pittenger, Christopher · 2012 · Biological Psychiatry
28. Depressive-like effects of the kappa opioid receptor agonist salvinorin A are associated with decreased phasic dopamine release in the nucleus accumbens
    Stephanie R. Ebner, Mitchell F. Roitman, David N. Potter, Anna B. Rachlin, Elena H. Chartoff · 2010 · Psychopharmacology
29. LSD enhances the emotional response to music
    Mendel Kaelen, Frederick Streeter Barrett, Leor Roseman, Romy Lorenz, Neiloufar Family, Mark Bolstridge, H. Valerie Curran, Amanda Feilding, David Nutt, Robin Lester Carhart-Harris · 2015 · Psychopharmacology
30. Posttraumatic stress disorder and cannabis use in a nationally representative sample.
    Jesse R. Cougle, Marcel O. Bonn‐Miller, Anka A. Vujanovic, Michael J. Zvolensky, Kirsten A. Hawkins · 2011 · Psychology of Addictive Behaviors
31. Quantitation of N,N-dimethyltryptamine and Harmala alkaloids in human plasma after Oral dosing with Ayahuasca
    Callaway, J. C., Raymon, L. P., Hearn, W. L., McKenna, D. J., Grob, C. S., Brito, G. S., Mash, D. C. · 1996 · Journal of Analytical Toxicology
32. The Olivocerebellar Projection Mediates Ibogaine-Induced Degeneration of Purkinje Cells: A Model of Indirect, Trans-Synaptic Excitotoxicity
    Elizabeth O’Hearn, Mark E. Molliver · 1997 · Journal of Neuroscience
33. Chapter 1 Ibogaine: A review
    Kenneth Alper · 2001 · ˜The œAlkaloids. Chemistry and biology/˜The œalkaloids. Chemistry and biology
34. A role for cannabinoid CB1 receptors in mood and anxiety disorders
    Jeffrey M. Witkin, Eleni T. Tzavara, George G. Nomikos · 2005 · Behavioural Pharmacology
35. Psychedelics and Immunomodulation: Novel Approaches and Therapeutic Opportunities
    Szabo, Attila · 2015 · Frontiers in Immunology
36. Acute harmine administration induces antidepressive-like effects and increases BDNF levels in the rat hippocampus
    Fortunato, Jucélia J., Réus, Gislaine Z., Kirsch, Tamires R., Stringari, Roberto B., Stertz, Laura, Kapczinski, Flávio, Pinto, Joel P., Hallak, Jaime E., Zuardi, Antônio W., Crippa, José A. et al. · 2009 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
37. The content of ecstasy tablets: implications for the study of their long‐term effects
    Jon C. Cole, Mike Bailey, Harry R. Sumnall, Graham F. Wagstaff, Les King · 2002 · Addiction
38. Therapeutic potential of cannabis-related drugs
    Alexander, Stephen P.H. · 2016 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
39. PTSD Symptom Reports of Patients Evaluated for the New Mexico Medical Cannabis Program
    George R. Greer, Charles S. Grob, Adam L. Halberstadt · 2014 · Journal of Psychoactive Drugs
40. A review of acute effects of 3,4-methylenedioxymethamphetamine in healthy volunteers
    Dumont, G. J. H., Verkes, R. J. · 2006 · Journal of Psychopharmacology
41. Residential Psychedelic (LSD) Therapy for the Narcotic Addict: A Controlled Study
    Savage, Charles · 1973 · Archives of General Psychiatry
42. From “Special <scp>K</scp>” to “Special <scp>M</scp>”: The Evolution of the Recreational Use of Ketamine and Methoxetamine
    Corazza, Ornella, Assi, Sulaf, Schifano, Fabrizio · 2013 · CNS Neuroscience &amp; Therapeutics
43. LSD: My Problem Child
    Barbara Kohn, Albert Hofmann · 1981 · The Antioch Review
44. Entheogens
    Carl A. P. Ruck, Jeremy Bigwood, Danny Staples, Jonathan Ott, R. Gordon Wasson · 1979 · Journal of Psychedelic Drugs
45. Single-photon emission tomography imaging of monoamine transporters in impulsive violent behaviour
    Jari Tiihonen, Jyrki T. Kuikka, Kim A. Bergström, Jari Karhu, Heimo T. Viinamäki, Johannes Lehtonen, Tero Hallikainen, Jiwei Yang, Panu Hakola · 1997 · European Journal of Nuclear Medicine and Molecular Imaging
46. MDMA enhances “mind reading” of positive emotions and impairs “mind reading” of negative emotions
    Hysek, Cédric M., Domes, Gregor, Liechti, Matthias E. · 2012 · Psychopharmacology
47. Effects of MDMA and intranasal oxytocin on social and emotional processing
    Kirkpatrick, Matthew G, Lee, Royce, Wardle, Margaret C, Jacob, Suma, de Wit, Harriet · 2014 · Neuropsychopharmacology
48. The Effects of Subanesthetic Ketamine Infusions on Motivation to Quit and Cue-Induced Craving in Cocaine-Dependent Research Volunteers
    Dakwar, Elias, Levin, Frances, Foltin, Richard W., Nunes, Edward V., Hart, Carl L. · 2014 · Biological Psychiatry
49. A critical review of reports of endogenous psychedelic N, N-dimethyltryptamines in humans: 1955-2010.
    Barker, Steven A., McIlhenny, Ethan H., Strassman, Rick · 2012 · Drug Testing and Analysis
50. LSD and Genetic Damage
    Norman I. Dishotsky, William D. Loughman, Robert E. Mogar, Wendell R. Lipscomb · 1971 · Science
51. Hallucinatory and rewarding effect of salvinorin A in zebrafish: κ-opioid and CB1-cannabinoid receptor involvement
    Daniela Braida, Valeria Limonta, Simona Pegorini, Alessia D. Zani, Chiara Guerini‐Rocco, Enzo Gori, Mariaelvina Sala · 2007 · Psychopharmacology
52. Study of Lysergic Acid Diethylamide as an Analgesic Agent
    KAST, ERIC C., COLLINS, VINCENT J. · 1964 · Anesthesia &amp; Analgesia
53. Ecstasy, 3–4 Methylenedioxymethamphetamine (MDMA), a Fatality Associated with Coagulopathy and Hyperthermia
    I. S. Chadwick, P D Curry, A. Linsley, Anthony John Freemont, B. R. H. Doran · 1991 · Journal of the Royal Society of Medicine
54. Pharmacology of ayahuasca administered in two repeated doses
    dos Santos, Rafael G., Grasa, Eva, Valle, Marta, Ballester, Maria Rosa, Bouso, José Carlos, Nomdedéu, Josep F., Homs, Rosa, Barbanoj, Manel J., Riba, Jordi · 2012 · Psychopharmacology
55. The Psychedelic Explorer's Guide: Safe, Therapeutic, and Sacred Journeys
    James Fadiman · 2011
56. Comparison of the reactions induced by psilocybin and LSD-25 in man
    Harris Isbell · 1959 · Psychopharmacology
57. Psychoactive Substances in Prehistoric Times: Examining the Archaeological Evidence
    Elisa Guerra Doce · 2015 · Time and Mind
58. Attenuation of alcohol intake by Ibogaine in three strains of alcohol-preferring rats
    Amir H. Rezvani, David H. Overstreet, Yue-Wei Leef · 1995 · Pharmacology Biochemistry and Behavior
59. Psychedelic drugs and mystical experience.
    Walter N. Pahnke · 1969 · PubMed
60. Psychotherapy with lysergic acid diethylamide
    EISNER, BETTY GROVER, COHEN, SIDNEY · 1958 · The Journal of Nervous and Mental Disease
61. Psychedelic Agents in Creative Problem-Solving: A Pilot Study
    Willis W. Harman, Robert H. McKim, Robert E. Mogar, James Fadiman, Myron J. Stolaroff · 1966 · Psychological Reports
62. Autonomic, Neuroendocrine, and Immunological Effects of Ayahuasca
    RAFAEL GUIMARÃES DOS SANTOS, Marta Valle, José Carlos Bouso, Josep F. Nomdedeu, José Rodrı́guez-Espinosa, Ethan H. McIlhenny, Steven A. Barker, Manel J. Barbanoj, Jordi Riba · 2011 · Journal of Clinical Psychopharmacology
63. Human psychopharmacology and dose-effects of salvinorin A, a kappa opioid agonist hallucinogen present in the plant Salvia divinorum
    Matthew W. Johnson, Katherine A. MacLean, Chad J. Reissig, Thomas Edward Prisinzano, Roland R. Griffiths · 2010 · Drug and Alcohol Dependence
64. Residual neuropsychological effects of illicit 3,4-methylenedioxymethamphetamine (MDMA) in individuals with minimal exposure to other drugs
    John H. Halpern, Harrison Graham Pope, Andrea R Sherwood, Steven Barry, James I. Hudson, Deborah A Yurgelun-Todd · 2004 · Drug and Alcohol Dependence
65. The Therapeutic Potential of κ-Opioids for Treatment of Pain and Addiction
    Charles Chavkin · 2010 · Neuropsychopharmacology
66. Dose-related effects of salvinorin A in humans: dissociative, hallucinogenic, and memory effects
    Katherine A. MacLean, Matthew W. Johnson, Chad J. Reissig, Thomas Edward Prisinzano, Roland R. Griffiths · 2012 · Psychopharmacology
67. Untitled work
    2008 · PubMed
68. Differential tolerance to biological and subjective effects of four closely spaced doses of N,N-dimethyltryptamine in humans.
    Strassman, Rick J., Qualls, Clifford R., Berg, Laura M. · 1996 · Biological Psychiatry
69. The Anti-Addiction Drug Ibogaine and the Heart: A Delicate Relation
    Xaver Koenig, Karlheinz Hilber · 2015 · Molecules
70. Thermoregulatory effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans
    Robert R. Freedman, Chris‐Ellyn Johanson, Manuel E. Tancer · 2005 · Psychopharmacology
71. Peyote in the Treatment of Alcoholism Among American Indians
    ALBAUGH, BERNARD J., ANDERSON, PHILIP O. · 1974 · American Journal of Psychiatry
72. LSD as an agonist of dopamine receptors in the striatum
    L. Pieri, Margherita Pieri, Willy E. Haefely · 1974 · Nature
73. Psilocybin dose-dependently causes delayed, transient headaches in healthy volunteers
    Matthew W. Johnson, Richard Andrew Sewell, Roland R. Griffiths · 2011 · Drug and Alcohol Dependence
74. Interactions between ibogaine, a potential anti-addictive agent, and morphine: an in vivo microdialysis study
    Maisonneuve, I.M., Keller, R.W., Glick, S.D. · 1991 · European Journal of Pharmacology
75. Ecstasy: Are animal data consistent between species and can they translate to humans?
    Neil Easton, Charles Alexander Marsden · 2006 · Journal of Psychopharmacology
76. Studies on lysergic acid diethylamide (LSD-25). I. Effects in former morphine addicts and development of tolerance during chronic intoxication.
    Richard E. Belleville, H. F. Fraser, Harris Isbell, C R LOGAN, Abraham Wikler · 1956 · PubMed
77. Dose-Related Behavioral, Subjective, Endocrine, and Psychophysiological Effects of the κ Opioid Agonist Salvinorin A in Humans
    Mohini Ranganathan, Ashley M. Schnakenberg Martin, Patrick D. Skosnik, Bruce M. Cohen, Brian P. Pittman, Richard Andrew Sewell, Deepak Cyril D’Souza · 2012 · Biological Psychiatry
78. Therapeutic mechanisms of classic hallucinogens in the treatment of addictions: from indirect evidence to testable hypotheses
    Michael P. Bogenschutz, Jessica M. Pommy · 2012 · Drug Testing and Analysis
79. A database of [18F]-altanserin binding to 5-HT2A receptors in normal volunteers: normative data and relationship to physiological and demographic variables
    Karen Husted Adams, Lars Hageman Pinborg, Claus Svarer, Steen Gregers Hasselbalch, Søren Holm, Steven Haugbøl, Karine Madsen, Vibe G. Frøkjær, Lars Martiny, Olaf Bjarne Paulson et al. · 2004 · NeuroImage
80. Over 30 million psychedelic users in the United States
    Krebs, Teri S, Johansen, Pål-Ørjan · 2013 · F1000Research
81. Comparison of psilocin with psilocybin, mescaline and LSD-25
    Albert B. Wolbach, Edward J. Miner, Harris Isbell · 1962 · Psychopharmacology
82. Therapeutic infusions of ketamine: do the psychoactive effects matter?
    Dakwar, E., Anerella, C., Hart, C.L., Levin, F.R., Mathew, S.J., Nunes, E.V. · 2014 · Drug and Alcohol Dependence
83. The psychedelic model of schizophrenia: the case of N,N- dimethyltryptamine
    J. Christian Gillin, J Kaplan, Richard C. Stillman, Richard Jed Wyatt · 1976 · American Journal of Psychiatry
84. Report on psychoactive drug use among adolescents using ayahuasca within a religious context.
    Doering-Silveira, Evelyn, Grob, Charles S., de Rios, Marlene Dobkin, Lopez, Enrique, Alonso, Luisa K., Tacla, Cristiane, Da Silveira, Dartiu Xavier · 2005 · Journal of Psychoactive Drugs
85. The origin and use of cannabis in eastern asia linguistic-cultural implications
    Huilin Li · 1974 · Economic Botany
86. Ketamine as a promising prototype for a new generation of rapid‐acting antidepressants
    Abdallah, Chadi G., Averill, Lynnette A., Krystal, John H. · 2015 · Annals of the New York Academy of Sciences
87. Effects of ibogaine on acute signs of morphine withdrawal in rats: Independence from tremor
    S.D. Glick, Kent L. Rossman, N.C. Rao, I.M. Maisonneuve, Jeffrey N. Carlson · 1992 · Neuropharmacology
88. ‘Altered States of Consciousness and Short-Term Psychological After-Effects Induced by the First Time Ritual Use of Ayahuasca in an Urban Context in Brazil’
    Barbosa, Paulo Cesar Ribeiro, Giglio, Joel Sales, Dalgalarrondo, Paulo · 2005 · Journal of Psychoactive Drugs
89. 18-Methoxycoronaridine, a non-toxic iboga alkaloid congener: effects on morphine and cocaine self-administration and on mesolimbic dopamine release in rats
    S.D. Glick, Martin E. Kuehne, I.M. Maisonneuve, Upul K. Bandarage, Helen H. Molinari · 1996 · Brain Research
90. Endogenous psychoactive tryptamines reconsidered: an anxiolytic role for dimethyltryptamine
    Michael Jacob, David E. Presti · 2005 · Medical Hypotheses
91. Mitigation of post‐traumatic stress symptoms by <i>Cannabis</i> resin: A review of the clinical and neurobiological evidence
    Passie, Torsten, Emrich, Hinderk M., Karst, Matthias, Brandt, Simon D., Halpern, John H. · 2012 · Drug Testing and Analysis
92. LSD Revisited
    William H. McGlothlin · 1971 · Archives of General Psychiatry
93. Long Lasting Effects of LSD on Normals
    William H. McGlothlin · 1967 · Archives of General Psychiatry
94. Equasy — An overlooked addiction with implications for the current debate on drug harms
    David Nutt · 2009 · Journal of Psychopharmacology
95. Cannabis for migraine treatment: the once and future prescription? An historical and scientific review
    Ethan B. Russo · 1998 · Pain
96. Medication development of ibogaine as a pharmacotherapy for drug dependence.
    Deborah C. Mash, Craig A. Kovera, Billy E. Buck, Michael D. Norenberg, Paul Shapshak, William Lee Hearn, Juan Sanchez‐Ramos · 1998 · PubMed
97. Treatment of Alcoholism Using Psychedelic Drugs: A Review of the Program of Research
    Mariavittoria Mangini · 1998 · Journal of Psychoactive Drugs
98. Beyond the K‐hole: a 3‐year longitudinal investigation of the cognitive and subjective effects of ketamine in recreational users who have substantially reduced their use of the drug
    Celia J. A. Morgan, Lisa Monaghan, H. Valerie Curran · 2004 · Addiction
99. The role of dextromethorphan in pain control
    Avi A. Weinbroum, Valery Rudick, Gideon Paret, Ron Ben‐Abraham · 2000 · Canadian Journal of Anesthesia/Journal canadien d anesthésie
100. Ayahuasca in Adolescence: A Preliminary Psychiatric Assessment
     Da Silveira, Dartiu Xavier, Grob, Charles S., de Rios, Marlene Dobkin, Lopez, Enrique, Alonso, Luisa K., Tacla, Cristiane, Doering-Silveira, Evelyn · 2005 · Journal of Psychoactive Drugs
101. Health status of ayahuasca users
     Barbosa, Paulo Cesar Ribeiro, Mizumoto, Suely, Bogenschutz, Michael P., Strassman, Rick J. · 2012 · Drug Testing and Analysis
102. Signaling via CNS cannabinoid receptors
     Ken Mackie · 2008 · Molecular and Cellular Endocrinology
103. The Use of Cannabis as a Mood Stabilizer in Bipolar Disorder: Anecdotal Evidence and the Need for Clinical Research
     Lester Grinspoon, James B. Bakalar · 1998 · Journal of Psychoactive Drugs
104. Medication Development of Ibogaine as a Pharmacotherapy for Drug Dependencea
     Deborah C. Mash, Craig A. Kovera, Billy E. Buck · 1998 · Annals of the New York Academy of Sciences
105. Use of <i>d</i>-Lysergic Acid Diethylamide in the Treatment of Alcoholism
     Chwelos, N., Blewett, D. B., Smith, C. M., Hoffer, A. · 1959 · Quarterly Journal of Studies on Alcohol
106. Ecstasy: The Clinical, Pharmacological and Neurotoxicological Effects of the Drug MDMA
     1990 · Topics in the neurosciences
107. (±)-3,4-Methylenedioxymethamphetamine (MDMA, ‘Ecstasy’) increases social interaction in rats
     Kirsten C. Morley, Iain S. McGregor · 2000 · European Journal of Pharmacology
108. Neuropharmacology of the Naturally Occurring κ-Opioid Hallucinogen Salvinorin A
     Christopher W. Cunningham, Richard B. Rothman, Thomas Edward Prisinzano · 2011 · Pharmacological Reviews
109. When the Endogenous Hallucinogenic Trace AmineN,N-Dimethyltryptamine Meets the Sigma-1 Receptor
     Tsung‐Ping Su, Teruo Hayashi, D. Bruce Vaupel · 2009 · Science Signaling
110. MDMA-assisted therapy: A new treatment model for social anxiety in autistic adults
     Alicia L. Danforth, Christopher M. Struble, Berra Yazar‐Klosinski, Charles S. Grob · 2015 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
111. How LSD Originated
     Albert Hofmann · 1979 · Journal of Psychedelic Drugs
112. Treating drug dependence with the aid of ibogaine: A retrospective study
     Eduardo Ekman Schenberg, Maria Angélica de Castro Comis, Bruno Rasmussen Chaves, Dartiu Xavier da Silveira · 2014 · Journal of Psychopharmacology
113. A possibly sigma-1 receptor mediated role of dimethyltryptamine in tissue protection, regeneration, and immunity.
     Frecska, Ede, Szabo, Attila, Winkelman, Michael J., Luna, Luis E., McKenna, Dennis J. · 2013 · Journal of Neural Transmission
114. A Six-Month Prospective Evaluation of Personality Traits, Psychiatric Symptoms and Quality of Life in Ayahuasca-Naïve Subjects
     Paulo César Ribeiro Barbosa, Irene Maurício Cazorla, Joel Sales Giglio, Rick J. Strassman · 2009 · Journal of Psychoactive Drugs
115. Vasopressin and oxytocin secretion in response to the consumption of ecstasy in a clubbing population
     Wolff, K., Tsapakis, E. M., Winstock, A. R., Hartley, D., Holt, D., Forsling, M. L., Aitchison, K. J. · 2006 · Journal of Psychopharmacology
116. Fatalities Temporally Associated with the Ingestion of Ibogaine
     Kenneth Alper, Marina Stajić, James R. Gill · 2012 · Journal of Forensic Sciences
117. Receptor binding profile suggests multiple mechanisms of action are responsible for ibogaine's putative anti-addictive activity
     Paul M. Sweetnam, J. Lancaster, Adele M. Snowman, Judith L. Collins, Scott E. Perschke, C. Bauer, John W. Ferkany · 1995 · Psychopharmacology
118. Involvement of κ-Opioid and Endocannabinoid System on Salvinorin A-Induced Reward
     Daniela Braida, Valeria Limonta, Valeria Capurro, Paola Fadda, Tiziana Rubino, Paola Mascia, Alessia D. Zani, Enzo Gori, Walter Fratta, Daniela Parolaro et al. · 2007 · Biological Psychiatry
119. Dimethyltryptamine (DMT): Prevalence, user characteristics and abuse liability in a large global sample
     ADAM R. WINSTOCK, Stephen John Kaar, Rohan Borschmann · 2013 · Journal of Psychopharmacology
120. Mescaline use for 5700 years
     Jan G. Bruhn, Peter A. G. M. De Smet, Hesham Rushdey El-Seedi, Olof Beck · 2002 · The Lancet
121. Ibogaine in the Treatment of Substance Dependence
     Thomas Brown · 2013 · Current Drug Abuse Reviews
122. Indoleamine Hallucinogens in Cluster Headache: Results of the Clusterbusters Medication Use Survey
     Emmanuelle A. D. Schindler, Christopher H. Gottschalk, Marsha J. Weil, Robert E. Shapiro, Douglas A. Wright, Richard Andrew Sewell · 2015 · Journal of Psychoactive Drugs
123. A comparison of the binding profiles of dextromethorphan, memantine, fluoxetine and amitriptyline: Treatment of involuntary emotional expression disorder
     Linda L. Werling, Ashleigh B. Keller, Julie G. Frank, Samer J. Nuwayhid · 2007 · Experimental Neurology
124. A Word to the Wise About Ketamine
     Alan F. Schatzberg · 2014 · American Journal of Psychiatry
125. The plant-derived hallucinogen, salvinorin A, produces ?-opioid agonist-like discriminative effects in rhesus monkeys
     Eduardo R. Butelman, Todd J. Harris, Mary Jeanne Kreek · 2004 · Psychopharmacology
126. Transient reinforcing effects of phenylisopropylamine and indolealkylamine hallucinogens in rhesus monkeys
     Fantegrossi, W. E., Woods, J. H., Winger, G. · 2004 · Behavioural Pharmacology
127. Serotonergic psychedelics temporarily modify information transfer in humans.
     Alonso, Joan Francesc, Romero, Sergio, Mañanas, Miquel Àngel, Riba, Jordi · 2015 · International Journal of Neuropsychopharmacology
128. A Controlled Study of Lysergide in the Treatment of Alcoholism. I . The Effects on Drinking Behavior
     Reginald G. Smart, Thomas Storm, Earle F. W. Baker, Lionel P. Solursh · 1966 · Quarterly Journal of Studies on Alcohol
129. The Wondrous Mushroom. Mycolatry in Mesoamerica
     B. Lowy, R. Gordon Wasson · 1981 · Mycologia
130. Effects of β-carboline harmine on behavioral and physiological parameters observed in the chronic mild stress model: Further evidence of antidepressant properties
     Jucélia Jeremias Fortunato, Gislaine Z. Réus, Tamires R. Kirsch, Roberto B. Stringari, Gabriel R. Fries, Flávio Pereira Kapczinski, Jaime E. C. Hallak, Antônio Waldo Zuardi, José Alexandre S. Crippa, João Quevedo · 2009 · Brain Research Bulletin
131. Involvement of Sigma-1 Receptors in the Antidepressant-like Effects of Dextromethorphan
     Nguyen, Linda, Robson, Matthew J., Healy, Jason R., Scandinaro, Anna L., Matsumoto, Rae R. · 2014 · PLoS ONE
132. NMDA antagonist properties of the putative antiaddictive drug, ibogaine.
     Piotr Popik, Richard Thomas Layer, Linda H. Fossom, Morris Benveniste, Beth Geter-Douglass, Jeffrey M. Witkin, Phil Skolnick · 1995 · Journal of Pharmacology and Experimental Therapeutics
133. 4-Bromo-2,5-dimethoxyphenethylamine (2C-B): presence in the recreational drug market in Spain, pattern of use and subjective effects
     Fernando Caudevilla, Jordi Riba A, Mireia Ventura, Débora González, Magı́ Farré, Manel J. Barbanoj, José Carlos Bouso · 2012 · Journal of Psychopharmacology
134. The Peak Experience Variable in DPT-Assisted Psychotherapy with Cancer Patients
     W. A. Richards, J. Rhead, F. Dileo, R. Yensen, A. Kurland · 1977 · Journal of Psychedelic Drugs
135. Hallucinogenic Drugs in Psychiatric Research and Treatment Perspectives and Prospects
     R. Strassman · 1995 · Journal of Nervous and Mental Disease
136. The Discovery of Serotonin and its Role in Neuroscience
     Patricia M. Whitaker‐Azmitia · 1999 · Neuropsychopharmacology
137. MDMA alters emotional processing and facilitates positive social interaction
     Wardle, Margaret C., de Wit, Harriet · 2014 · Psychopharmacology
138. How could MDMA (ecstasy) help anxiety disorders? A neurobiological rationale
     Johansen, PØ, Krebs, TS · 2009 · Journal of Psychopharmacology
139. Lysergic Acid Diethylamide: Effect on Embryos
     Robert Auerbach, James A. Rugowski · 1967 · Science
140. An Exploration of the History and Controversies Surrounding MDMA and MDA
     Alana Rae. Pentney · 2001 · Journal of Psychoactive Drugs
141. Analysis of illicit ecstasy tablets: implications for clinical management in the accident and emergency department.
     Kellie Sherlock, Kim Wolff, Alastair W M Hay, Mark T. Conner · 1999 · Emergency Medicine Journal
142. Dextromethorphan: A Review of N‐methyl‐ d ‐aspartate Receptor Antagonist in the Management of Pain
     Anita Siu, Richard A. Drachtman · 2007 · CNS Drug Reviews
143. Chapter 8 Ibogaine in the treatment of heroin withdrawal
     Deborah C. Mash, Craig A. Kovera, John P. Pablo, Rachel Fynvola Tyndale, Frank R. Ervin, Jeffrey D Kamlet, William Lee Hearn · 2001 · The Alkaloids. Chemistry and biology/The alkaloids. Chemistry and biology
144. Cannabis use among military veterans after residential treatment for posttraumatic stress disorder.
     Marcel O. Bonn‐Miller, Anka A. Vujanovic, Kent D. Drescher · 2011 · Psychology of Addictive Behaviors
145. Abnormal visual experiences in individuals with histories of hallucinogen use: A web-based questionnaire
     Matthew J. Baggott, Jeremy Coyle, Earth Erowid, Fire Erowid, Lynn C. Robertson · 2010 · Drug and Alcohol Dependence
146. Serotonin 5-HT2 receptor activation prevents allergic asthma in a mouse model
     Felix Nau, J. Miller, J. Saravia, Terry A. Ahlert, Bang-Ning Yu, K. Happel, S. Cormier, Charles D. Nichols · 2015 · American Journal of Physiology-Lung Cellular and Molecular Physiology
147. High doses of dextromethorphan, an NMDA antagonist, produce effects similar to classic hallucinogens
     Chad J. Reissig, Lawrence P. Carter, Matthew W. Johnson, Miriam Z. Mintzer, Margaret A. Klinedinst, Roland R. Griffiths · 2012 · Psychopharmacology
148. Flashback: Psychiatric Experimentation with LSD in Historical Perspective
     Erika Dyck · 2005 · The Canadian Journal of Psychiatry
149. Hallucinogen use predicts reduced recidivism among substance-involved offenders under community corrections supervision
     Peter S. Hendricks, C Brendan Clark, Matthew W. Johnson, Kevin R. Fontaine, Karen L. Cropsey · 2014 · Journal of Psychopharmacology
150. MDMA and temperature: A review of the thermal effects of ‘Ecstasy’ in humans
     Andrew C. Parrott · 2011 · Drug and Alcohol Dependence
151. Continuous intravenous infusion of ketamine for maintenance sedation.
     Anton Miller, C T Jamin, E.M. Elamin · 2011 · PubMed
152. Tryptamine, N,N-Dimethyltryptamine, N,N-Dimethyl-5-hydroxytryptamine and 5-Methoxytryptamine in Human Blood and Urine
     Fr. Franzen, H Gross · 1965 · Nature
153. Human Indolethylamine N-Methyltransferase: cDNA Cloning and Expression, Gene Cloning, and Chromosomal Localization
     Michael A. Thompson, Eunpyo Moon, Ung-Jin Kim, Jingping Xu, Michael J. Siciliano, Richard M. Weinshilboum · 1999 · Genomics
154. EVIDENCE FOR THE PARTICIPATION OF SEROTONIN IN MENTAL PROCESSES
     D. W. Woolley, F. N. Shaw · 1957 · Annals of the New York Academy of Sciences
155. Prosocial effects of MDMA: A measure of generosity
     Matthew G. Kirkpatrick, Andrew W. Delton, Theresa E. Robertson, Harriet de Wit · 2015 · Journal of Psychopharmacology
156. Sex differences in kappa opioid pharmacology
     Khampaseuth Rasakham, Lee‐Yuan Liu‐Chen · 2010 · Life Sciences
157. Harmane Induces Anxiolysis and Antidepressant‐Like Effects in Rats
     Feyza Arıcıoğlu, H. Altunbas · 2003 · Annals of the New York Academy of Sciences
158. A New Mexican Psychotropic Drug from the Mint Family
     R. Gordon Wasson · 1962 · Botanical Museum leaflets Harvard University
159. Platelet serotonin uptake sites increased in drinkers ofayahuasca
     J. C. Callaway, Mauno M. Airaksinen, Dennis J. McKenna, Glacus S. Brito, Charles S. Grob · 1994 · Psychopharmacology
160. Attenuation of Alcohol Consumption by a Novel Nontoxic Ibogaine Analogue (18-Methoxycoronaridine) in Alcohol-Preferring Rats
     Amir H. Rezvani · 1997 · Pharmacology Biochemistry and Behavior
161. A preliminary naturalistic study of low-dose ketamine for depression and suicide ideation in the emergency department
     Gregory Luke Larkin, Annette L. Beautrais, Robert Turelli, Gerard Sanacora, Seth M. Powsner, Melanie J. Lippmann, John Harrison Krystal · 2011 · European Psychiatry
162. Psilocybin mushrooms of the world: an identification guide
     1997 · Choice Reviews Online
163. Unfavourable reactions to LSD: a review and analysis of the available case reports.
     Reginald G. Smart, K Bateman · 1967 · PubMed
164. Dextromethorphan and its metabolite dextrorphan block alpha3beta4 neuronal nicotinic receptors.
     S C Hernandez, M Bertolino, Yucai Xiao, Kenneth E. Pringle, F S Caruso, Kenneth J. Kellar · 2000 · PubMed
165. Salvinorin A, a kappa-opioid receptor agonist hallucinogen: pharmacology and potential template for novel pharmacotherapeutic agents in neuropsychiatric disorders
     Eduardo R. Butelman, Mary Jeanne Kreek · 2015 · Frontiers in Pharmacology
166. Use patterns and self-reported effects of Salvia divinorum: An internet-based survey
     Matthew J. Baggott, Earth Erowid, Fire Erowid, Gantt P. Galloway, John E. Mendelson · 2010 · Drug and Alcohol Dependence
167. Structure‐Activity Relationships of MDMA and Related Compounds: A New Class of Psychoactive Drugs?a
     David E. Nichols, Robert A. Oberlender · 1990 · Annals of the New York Academy of Sciences
168. Salvinorin-A Induces Intense Dissociative Effects, Blocking External Sensory Perception and Modulating Interoception and Sense of Body Ownership in Humans
     Ana Elda Maqueda, Marta Valle, Peter H. Addy, Rosa María Antonijoan, Montserrat Puntes, Jimena Coimbra, María Rosa Ballester, Maite Garrido, M. J. González, Judit Claramunt et al. · 2015 · The International Journal of Neuropsychopharmacology
169. MDMA effects consistent across laboratories
     Matthew G. Kirkpatrick, Matthew J. Baggott, John E. Mendelson, Gantt P. Galloway, Matthias E. Liechti, Cédric M. Hysek, Harriet de Wit · 2014 · Psychopharmacology
170. MDMA: Its History and Pharmacology
     David M. McDowell, Herbert D. Kleber · 1994 · Psychiatric Annals
171. Daytime Ayahuasca administration modulates REM and slow-wave sleep in healthy volunteers
     Manel J. Barbanoj, Jordi Riba A, S. Clos, Sandra Giménez, Eva Grasa, Sergio Romero · 2007 · Psychopharmacology
172. Ecstasy (MDMA) and memory function: a meta‐analytic update
     Keith R. Laws, Joy Kokkalis · 2007 · Human Psychopharmacology Clinical and Experimental
173. Biochemistry and Pharmacology of Tryptamines and β-Carbolines A Minireview
     Dennis J. McKenna, G.H.N. Towers · 1984 · Journal of Psychoactive Drugs
174. A Study of Ayahuasca Use in North America
     Harris, Rachel, Gurel, Lee · 2012 · Journal of Psychoactive Drugs
175. Mescaline, lysergic acid diethylamide and psilocybin: Comparison of clinical syndromes, effects on color perception and biochemical measures
     Leo E. Hollister, Alan M. Hartman · 1962 · Comprehensive Psychiatry
176. Ayahuasca in Adolescence: A Neuropsychological Assessment
     Evelyn Doering-Silveira, Enrique López, Charles S. Grob, Marlene Dobkin de Ríos, Luisa K. Alonso, Cristiane Tacla, Itiro Shirakawa, Paulo Henrique Ferreira Bertolucci, Dartiu Xavier da Silveira · 2005 · Journal of Psychoactive Drugs
177. LC/MS/MS analysis of the endogenous dimethyltryptamine hallucinogens, their precursors, and major metabolites in rat pineal gland microdialysate.
     Barker, Steven A., Borjigin, Jimo, Lomnicka, Izabela, Strassman, Rick · 2013 · Biomedical Chromatography
178. Dimethyltryptamine (DMT): Subjective effects and patterns of use among Australian recreational users
     Vince Cakic, Jacob Potkonyak, Alex Marshall · 2010 · Drug and Alcohol Dependence
179. Ibogaine induces glial activation in parasagittal zones of the cerebellum
     Elizabeth O’Hearn, David B. Long, Mark E. Molliver · 1993 · Neuroreport
180. Navajo Peyote Use: Its Apparent Safety
     Robert Bergman · 1971 · American Journal of Psychiatry
181. Changes in Spirituality Among Ayahuasca Ceremony Novice Participants
     Stephen Trichter, Jon Klimo, Stanley Krippner · 2009 · Journal of Psychoactive Drugs
182. The Use of Ketamine in Psychiatry
     E. Khorramzadeh, Abdelrahman Lotfy · 1973 · Psychosomatics
183. Neurocognitive function in current and ex-users of ecstasy in comparison to both matched polydrug-using controls and drug-naïve controls
     Rosa Hoshi, Kate Mullins, Catherine Boundy, Catherine M. Brignell, Paola P. Piccini, H. Valerie Curran · 2007 · Psychopharmacology
184. Metabolism of the hallucinogen N,N-dimethyltryptamine in rat brain homogenates
     Steven A. Barker, John A. Monti, Samuel T. Christian · 1980 · Biochemical Pharmacology
185. Posttraumatic stress and marijuana use coping motives: The mediating role of distress tolerance
     Carrie M. Potter, Anka A. Vujanovic, Erin C. Marshall‐Berenz, Amit Bernstein, Marcel O. Bonn‐Miller · 2010 · Journal of Anxiety Disorders
186. Stigma of mental illness in Japan
     E. Desapriya, Nobutada Iwase · 2002 · The Lancet
187. Acute and post-acute behavioral and psychological effects of salvinorin A in humans
     Peter H. Addy · 2011 · Psychopharmacology
188. The treatment of heroin addicts with dextromethorphan: a double-blind comparison of dextromethorphan with chlorpromazine.
     H. Koyuncuoǧlu, B Saydam · 1990 · PubMed
189. New World Tryptamine Hallucinogens and the Neuroscience of Ayahuasca
     Dennis J. McKenna, Jordi Riba A · 2016 · Current topics in behavioral neurosciences
190. Ecstasy Use Among Club Rave Attendees
     Amelia M. Arria, George S. Yacoubian, Elisabeth Fost, Eric D. Wish · 2002 · Archives of Pediatrics and Adolescent Medicine
191. Effect of ibogaine on naloxone-precipitated withdrawal syndrome in chronic morphine-dependent rats.
     Dzoljic Ed, Charles D. Kaplan, Dzoljic Mr · 1989 · PubMed
192. The role of 5-HT2A, 5-HT2C and mGlu2 receptors in the behavioral effects of tryptamine hallucinogens N,N-dimethyltryptamine and N,N-diisopropyltryptamine in rats and mice
     Theresa M. Carbonaro, Amy J. Eshleman, Michael J. Forster, Kejun Cheng, Kenner C. Rice, Michael B. Gatch · 2014 · Psychopharmacology
193. Neuropsychological function in ecstasy users: a study controlling for polydrug use
     Jonathan Paul Roiser, Robert David Rogers, Barbara Jacquelyn Sahakian · 2005 · Psychopharmacology
194. Intimate insight: MDMA changes how people talk about significant others
     Matthew J. Baggott, Matthew G. Kirkpatrick, Gillinder Bedi, Harriet de Wit · 2015 · Journal of Psychopharmacology
195. Chapter 2 Mechanisms of action of ibogaine: Relevance to putative therapeutic effects and development of a safer iboga alkaloid congener
     2001 · The Alkaloids: Chemistry and Biology
196. Ecstasy: the complete guide: a comprehensive look at the risks and benefits of MDMA
     2002 · Choice Reviews Online
197. Monoamine oxidase inhibitors in South American hallucinogenic plants part 2: Constituents of orally-active Myristicaceous hallucinogens
     Dennis J. McKenna, G.H.N. Towers, F. S. Abbott · 1984 · Journal of Ethnopharmacology
198. Neuronal correlates of visual and auditory alertness in the DMT and ketamine model of psychosis
     Jörg Daumann, Daniel R. Wagner, Karsten Heekeren, Anna Neukirch, Christiane M. Thiel, Euphrosyne Gouzoulis‐Mayfrank · 2009 · Journal of Psychopharmacology
199. Novel iboga alkaloid congeners block nicotinic receptors and reduce drug self-administration
     Christopher J. Pace, Stanley D. Glick, Isabelle M. Maisonneuve, Li-Wen He, Patrick A. Jokiel, Martin E. Kuehne, Mark W. Fleck · 2004 · European Journal of Pharmacology
200. TEONANACATL: THE NARCOTIC MUSHROOM OF THE AZTECS2
     Richard Evans Schultes · 1940 · American Anthropologist